We examined the hypothesis that impaired endothelium-dependent vasodilation in atherosclerosis is associated with decreased synthesis of nitrogen oxides by the vascular endothelium. The descending thoracic aortae of rabbits fed either normal diet, a high cholesterol diet for 2-5 wk (hypercholesterolemic, HC), or a high cholesterol diet for 6 mo (atherosclerotic, AS) were perfused in a bioassay organ chamber with physiologic buffer containing indomethacin. Despite a dramatic impairment in the vasodilator activity of endothelium-dependent relaxing factor (EDRF) released from both HC and AS aortae (assessed by bioassay), the release of nitrogen oxides (measured by chemiluminescence) from these vessels was not reduced, but markedly increased compared to NL. Thus, impaired endothelium-dependent relaxation in atherosclerosis is neither due to decreased activity of the enzyme responsible for the production of nitrogen oxides from arginine nor to arginine deficiency. Because the production of nitrogen oxides increased in response to acetylcholine in both hypercholesterolemic and atherosclerotic vessels, impairments in signal transduction are not responsible for abnormal endothelium-dependent relaxations. Impaired vasodilator activity of EDRF by cholesterol feeding may result from loss of incorporation of nitric oxide into a more potent parent compound, or accelerated degradation of EDRF.
Introduction
The endothelium-derived relaxing factor (EDRF)' is a labile non-prostanoid compound with potent vasodilator properties, which is either nitric oxide or a related nitrosylated compound (1, 4) . An enzyme-responsible nitric oxide production by oxidation of the guanidino nitrogens of arginine, recently termed nitric oxide synthetase, has now been identified in several mammalian tissues including brain (5, 6) , hepatocytes (7), lung (8) , macrophages (9, 10) , and endothelial cells (1 1-14) . This enzyme requires NADPH (5, 8, 14) , calmodulin (15) , and the macrophage enzyme has been reported to require biopterin (16) . Recently, a 150-kD protein with the properties of this enzyme had been purified to homogeneity from brain homogenate (15) . It has also been suggested that endothelial cells possess both a calcium-dependent enzyme located in the cytoplasm and a membrane-associated, calcium-independent enzyme that participate in the synthesis of nitric oxide (13) .
Atherosclerosis impairs endothelium-dependent vasodilation in both animal models (17) (18) (19) (20) (21) (22) (23) and human coronary arteries (24, 25) , and thereby may predispose to vasoconstriction and arterial spasm. Bioassay studies have suggested that the mechanism underlying this defect in endothelial cell function is decreased EDRF production or release of a defective EDRF (26) . It is therefore reasonable to suspect that cholesterol feeding and atherosclerosis might impair the function of the endothelial cell nitric oxide synthetase, either by a direct effect on the enzyme or by depletion of one or more of the required co-factors. Alternatively, it has been suggested that cholesterol feeding may alter endothelial cell receptors or second messenger systems such that the enzyme is not normally activated upon agonist stimulation (24) .
In these experiments, we sought to examine the effect of both short-and long-term cholesterol feeding on the enzymatic process leading to the production of nitrogen oxides by the vascular endothelium. We employed a chemiluminescence technique to allow accurate determination of the release of nitric oxide and one electron oxidation product of nitric oxide from rabbit aorta under basal conditions and during administration of either acetylcholine or the calcium ionophore. The vasorelaxant activity of EDRF released from these vessels was concomitantly quantified by bioassay.
Methods
Cholesterol feeding protocol. New Zealand white rabbits were randomly assigned to treatment and control groups. Hypercholesterolemia was induced by feeding a 1% cholesterol diet for 2-5 wk (n = 7). Atherosclerosis was caused by continuing the 1% diet for 4 mo, followed by a 0.5% diet for 2 mo (n = 8). Age-matched controls (n = 10) were maintained on standard rabbit chow (Continental Grain, Chicago, IL).
Preparation of bioassay vascular ring for detection of EDRF. Bioassay detector rings were prepared from 3-5- NaHCO3, 1 1.1 glucose, pH 7.40, warmed to 37°C, and aerated with 95% 02, (5% C02), or by effluent from an aortic segment suspended in an organ bath (Fig. 1) . Rates of superfusion were identical (4 ml/min).
Before each study, the detector rings were gradually stretched to an optimal resting tension of 1-2 g over a period of 2 h. Active tension of 3-4 g was then obtained by administration of 0.1-1 ,uM of prostaglandin F2at. Denudation was confirmed by the absence of relaxation to direct application of bradykinin (0.01 M).
Preparation ofthoracic rabbit aorta as EDRF donor. On the day of the study, rabbits were killed by an overdose of pentobarbital. The descending thoracic aorta was isolated and removed, taking care to not damage the endothelium. The segment was immediately cannulated with stainless steel cannulas and mounted in an organ bath filled with Kreb's solution. An identical solution was continuously perfused in the direction of normal flow through the aortic segment. The aortic effluent could be directed to either the bioassay vascular segment, or to the collection chamber of the nitric oxide analyzer (Fig. 1) .
Measurement of nitric oxide by chemiluminescence. The effluent from the aortic segment was directed into a collection chamber containing a solution of 1% NaI and glacial acetic acid under reflux conditions ( Fig. 1 ). This strong reducing environment is required for preserving nitric oxide in its authentic form, and also converts a number of nitrosyl compounds (including secondary nitrosoamines, nitrosothiols, and nitrite) to nitric oxide (4) . A constant stream of inert nitrogen gas under vacuum carried nitric oxide gas released from this chamber into the nitric oxide analyzer (Dasibi, model 2108; Glendale, CA) where the gas was exposed to ozone at 45°C. The reaction of ozone with nitric oxide releases light at a wavelength of6,500-8,000 A. The amount oflight generated by this reaction is linearly related to the quantity of nitric oxide present. The emitted light was detected by a photomultiplier tube, generating a DC signal, which was recorded on an oscillographic direct writing recorder. Drugs. Bradykinin, acetylcholine, atropine, the calcium ionophore A23187, and indomethacin were all obtained from Sigma Chemical F2, was obtained from Upjohn (Chicago, IL). Drugs were dissolved in distilled water and subsequently diluted in the physiologic buffer to desired concentrations, except for indomethacin, which was dissolved in 0.9% NaCl with the pH adjusted to 8 by addition of 1 N NaOH. All agents were prepared immediately before experiments.
Protocol. All studies were performed in the presence ofindomethacin (I AM) to inhibit the synthesis of cyclooxygenase products. Measurements ofEDRF and nitrogen oxides (NO, NO-, R-NO) within the effluent of aortic segments were made after 10 min of perfusion with control physiologic buffer. Transit times from the aortic segment to the detector vessel and to the reflux chamber of the nitric oxide analyzer were identical (3 s). The physiologic buffer was infused at the rate of 4 ml/min through both the direct superfusion channel and the aortic segments. The bioassay detector vessel was initially superfused through the direct channel, bypassing the donor aortic segment. After a stable preconstriction was obtained, effluent from the rabbit aorta was directed onto the detector vessel, and the basal response was observed (Fig. 2) . When the response reached a stable baseline, the effluent was directed into the collection chamber ofthe nitric oxide analyzer, where it underwent reduction preprocessing. Nitric oxide that was recovered from the effluent was then measured by chemiluminescence.
The release of EDRF and nitrosyl compounds in response to acetylcholine (1 MM) was then examined. During administration of acetylcholine, atropine (10 MM) was simultaneously infused onto the detector vessel to block smooth muscle muscarinic receptors. Acetylcholine was infused at a constant rate into the aortic segment, while effluent from the aorta remained directed to the denuded bioassay detector vessel. After a stable relaxation was recorded, the effluent was directed into the collection chamber of the nitric oxide analyzer and nitric oxide measurements were recorded.
An identical protocol was subsequently employed to examine the effect of the calcium ionophore A23 187 (10 MM). Before the administration of A23 187, a second basal response was recorded. An interval of at least 15 min was allowed after cessation of acetylcholine before infusions of A23 187.
In studies where L-NMMA was employed, this compound was infused proximal to the aortic segments at least 10 min before examining basal and agonist-stimulated production ofEDRF and nitric oxide.
Cholesterol determinations. Blood samples were obtained directly from the heart at the time of death, and total serum cholesterol levels were determined as previously described (27). Control solution was initially superfused onto the detector vessel and preconstricted tension was obtained. Effluent from the aortic segment was then directed to the ring detector (e) and basal responses were recorded. Effluent was then immediately diverted into the reflux chamber of the nitric oxide analyzer (4), and nitric oxide signals were recorded, as control solution was again superfused onto the detector. This protocol was repeated during administration of acetylcholine (1 AM) and subsequently the calcium ionophore (10 MM). During administration of Ach, atropine (10 MM) was directly superfused onto the detector.
Histology and electron microscopy studies ofaortic segments and endothelium. 1 cm-segments of the upper thoracic aorta were fixed in 10% formaldehyde, and sectioned for microscopic evaluation of intimal lesions and endothelial integrity. In addition, an adjacent segment was fixed in 3% glutaraldehyde and processed for scanning and transmission electron microscopy.
Data analysis. Data are presented as mean±SEM. Responses ofthe detector ring to vasoactive substances released under basal conditions were expressed as a percentage ofpreconstricted tension. In the case of the hypercholesterolemic and atherosclerotic vessels, the effluent caused a slight paradoxic vasoconstriction, expressed as a negative value. Traditionally, relaxations of vascular rings are expressed in a cumulative fashion, i.e., the relaxation to acetylcholine and the relaxation due to basally released EDRF added together and expressed as a percent ofthe preconstricted tension. As effluent from hypercholesterolemic and atherosclerotic vessels produced a slight vasoconstriction under basal conditions, responses to either acetylcholine or A23187 were expressed using two approaches. The traditional (cumulative) approach used the formula: % relaxation = (grams tension before basal response -grams tension after relaxation/grams tension before basal response).
In addition we analyzed relaxations to acetylcholine and A23 187 excluding the basal response. This analysis employed the formula: % relaxation = (grams tension after basal response -grams remaining after relaxation/grams tension after basal response).
The amount of nitric oxide recovered from the aortic effluent was expressed as parts per million. Data regarding EDRF vasodilator activity (bioassay) and nitric oxide release (chemiluminescence) were identical for both short-term and long-term age-matched control groups, and therefore combined for statistical analyses. Statistical significance was assessed by analysis of variance. When differences were indicated, a Scheffe's test was used for comparison between groups. Differences were considered significant when P < 0.05.
Results
Plasma cholesterol levels. The plasma cholesterol levels were 38±4, 1448±62, and 1768±244 mg/dl for the control, shortterm, and long-term cholesterol fed groups, respectively.
Morphologic changes. Microscopic examination ofthe atherosclerotic aortae revealed prominent lesions with intimal thickening (Fig. 3) . Despite similar elevations in tissue cholesterol content, intimal lesions had not yet developed in hypercholesterolemic vessels (Fig. 4) . Intimal thickening was absent in control vessels. The endothelium appeared intact in all vessels on scanning and transmission electron microscopy studies.
Effects ofcholesterolfeeding on EDRF production. Detector vessels were preconstricted to a resting tension of 4.0±0.2, 3.8±0.2, and 4.0±0.2 g for hypercholesterolemic, atherosclerotic, and control vessel studies, respectively (P = NS). Cholesterol feeding markedly impaired EDRF vasodilator activity as measured in bioassay (Fig. 5) . Under basal flow conditions, effluent from normal vessels consistently caused relaxation of detectors. In contrast, effluent from both hypercholesterolemic and atherosclerotic vessels caused a tonic constriction. EDRF release elicited by the receptor-mediated agonist, acetylcholine (1 ,M), from normal vessels was sufficient to cause significant additional relaxations of detectors, but the vasodilator activity of EDRF released from hypercholesterolemic and atherosclerotic vessels was dramatically impaired. Effluent from normal vessels stimulated with A23187 (10 uM) caused significant additional relaxations; and similar additional relaxations were evoked by EDRF produced from hypercholesterolemic vessels. However, atherosclerosis dramatically impaired the vasodilator activity of EDRF released by A23187. These conclusions were valid using an analysis either including or excluding the basal response (Fig. 5) .
Detection of nitric oxide release by chemiluminescence. Despite significant impairment of the vasodilator activity of EDRF by cholesterol feeding, the quantity of nitric oxide recovered from the effluent of hypercholesterolemic and atherosclerotic vessels was significantly greater than in controls, and increased in response to agonists also (Fig. 6) . The quantity of nitric oxide recovered from the effluent of hypercholesterolemic vessels was also greater than that from atherosclerotic vessels, although this did not reach statistical significance.
To contrast the vasodilator potencies of nitrogen oxides released from the aortae of normal, hypercholesterolemic, and atherosclerotic animals, the grams of relaxation produced by acetylcholine and the calcium ionophore is presented as a function of nitric oxide detected from each (Fig. 7) . As is apparent, the amount of relaxation produced by the nitrogen oxides from hypercholesterolemic and atherosclerotic vessels is markedly reduced, suggesting that they have been released in a relatively inactive state.
Effects ofL-NMMA on nitric oxide release and EDRF production. It has been suggested that multiple EDRFs exist (21) . One explanation for impaired EDRF vasodilator activity in the presence of increased production of nitrosyl compounds is that cholesterol feeding impairs an EDRF unassociated with nitric oxide. To test this hypothesis, we examined the effect of a selective inhibitor of nitric oxide production, L-NMMA (5, 6), on EDRF released from normal rabbit aorta (n = 4). Nitric oxide release after L-NMMA (300 uM) was undetectable during all study conditions. Relaxations to acetylcholine and A23187 were calculated from the formula: % relaxation = (grams relaxation/grams of tension after basal response). The vasodilator activity of basally released EDRF, detected by bioassay, was abolished by L-NMMA and converted to a constriction of 21±8% (Fig. 8 ). L-NMMA had no direct effect on the denuded detector vessel. Acetylcholine (1 gM) caused no detectable release of a relaxing substance, and the release of EDRF by A23 187 (10 lM) was nearly abolished (4±3% relaxation). Thus, these experiments established that nitric oxide or a related nitrosyl compound is the primary EDRF produced by rabbit aorta, and that abnormalities ofendothelium-dependent vasodilation induced by cholesterol feeding are solely related to a defect in the synthesis or release of this compound.
Discussion
The first important finding of this study was that both shortterm and long-term cholesterol feeding resulted in an apparent decrease in EDRF production, as evidenced by impaired vasodilator activity in bioassay. This finding confirms previous work (26) . A second important finding was that the release of nitrosyl compounds from either hypercholesterolemic or atherosclerotic vessels was not reduced, but actually markedly increased. Finally, the production of these compounds from the vascular endothelium was further increased in response to acetylcholine and A23 187 after cholesterol feeding. The incre- ment in nitric oxide synthesis after agonist administration was substantially greater than that observed from normal vessels under all conditions examined. These observations clearly demonstrate that the enzymatic process responsible for the production of nitric oxide by the vascular endothelium is not impaired by either short-term or long-term cholesterol feeding. Furthermore, neither hypercholesterolemia nor atherosclerosis impairs the signal transduction mechanisms responsible for activation of this enzyme.
The two most likely explanations for these observations are either that cholesterol feeding prevents incorporation of nitric oxide into a more potent nitrosylated compound, or that cholesterol feeding accelerates the intracellular or extracellular degradation of EDRF (either NO to NO-or R-NO to R-+ NO-). The methodology used to detect nitric oxide by chemiluminescence in this study and others (1, 3, 4) does not distinguish free nitric oxide from a variety of nitrosylated compounds. We and others have found that one such compound, S-nitrosocysteine, more closely resembles EDRF than does nitric oxide (4, 29) . It is possible that incorporation of nitric oxide into a compound such as a nitrosothiol may be prevented after cholesterol feeding. This could occur as a result of oxidation of endothelial cell sulfhydryl groups to the disulfide form. Thus, cholesterol feeding could deplete essential EDRF substrates and therefore prevent the release of nitrosylated compounds that are substantially more stable and potent than nitric oxide.
The increased release of oxygen radicals could also result in accelerated degradation of either nitric oxide or a related compound to an inactive form (30, 31). Products of oxidized LDL could contribute to this process (32) .
There are several other less likely explanations for the increased release of apparently nonvasoactive nitrosyl compounds as a result of cholesterol feeding. If multiple relaxing factors are released by the endothelium, one explanation for the present findings is that atherosclerosis impairs an EDRF unrelated to nitric oxide. L-NMMA, a competitive inhibitor of L-arginine, virtually abolished the release of any detectable relaxing substance while blocking the synthesis of nitric oxide (Fig. 8) . Therefore, a nitrosylated compound appears to be the major EDRF released by rabbit aorta. Thus, it is unlikely that these findings could be explained by multiple relaxing factors.
Activated macrophages (9, 10, 16) and neutrophils (23) can produce nitric oxide and nitrite. Therefore, another explanation for our findings is that cholesterol feeding actually does impair nitric oxide synthesis from the endothelium, and that the excess nitric oxide detected by chemiluminescence was (Fig. 4 B) . Despite these histological findings, the amount of nitric oxide recovered from the effluent of hypercholesterolemic vessels was actually greater than that from atherosclerotic vessels. Therefore, the increased amount of nitric oxide detected after cholesterol feeding could not have been solely related to the presence of subendothelial macrophages.
A third explanation for our findings is that cholesterol feeding increases the release of vasoconstrictors from the endothelium. Constricting factors released in response to acetylcholine or the calcium ionophore could have reduced the apparent potency of EDRF released by these agonists, while not affecting nitric oxide signals. In previous studies we have been unable to detect the excess release of vasoconstrictor factors from the aortae of cholesterol-fed rabbits. In this study, the aortae of cholesterol-fed rabbits released a constricting factor under basal conditions. This, however, likely represented the effect of normally released constrictor factors by the endothelium, as L-NMMA also unmasked a similar basal constriction from normal vessels (Fig. 7) . The known constricting factors include the polypeptide endothelin (34) and one or more products of the cyclooxygenase pathway (35, 36) . It is not known if cholesterol feeding alters the production of endothelin. Enhanced release of prostanoids could not have accounted for our observations because experiments were performed in the presence of indomethacin. In these studies, the production of nitrosyl compounds with minimal vasodilator activity by hypercholesterolemic and atherosclerotic vessels was increased compared with normal vessels. Further augmentation of release of these compounds in response to agonists clearly shows that the signal transduction mechanisms responsible for nitric oxide synthesis are not impaired as a result of atherosclerosis. This finding is in clear contradistinction to conclusions drawn from observations of endothelium-dependent vascular relaxation of intact atherosclerotic vessel rings (24) . Further, these studies illustrate the importance of directly assessing the activity of the enzyme responsible for production of nitrosyl compounds (and presumably EDRF), rather than indirect assessment of EDRF release via simple measurements of endothelium-dependent relaxations in intact vascular rings. Arginine deficiency also does not appear to result from cholesterol feeding. These findings strongly suggest that the enzymatic process responsible for nitric oxide synthesis is upregulated, rather than impaired, as a result of cholesterol feeding. It is interesting to speculate that either the inability to synthesize a parent nitrosylated compound, or the accelerated intracellular degradation of EDRF, leads to a loss of feedback inhibition increasing the production of nitrosyl compounds from arginine. Thus, an important autocrine function for EDRF may exist. 
